AstraZeneca
AZN
AZN
1,127 hedge funds and large institutions have $34B invested in AstraZeneca in 2023 Q4 according to their latest regulatory filings, with 148 funds opening new positions, 396 increasing their positions, 360 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $33.7B → $34B (+$287M)
0.47% more ownership
Funds ownership: 32.1% → 32.57% (+0.47%)
13% less funds holding in top 10
Funds holding in top 10: 15 → 13 (-2)
Holders
1,127
Holding in Top 10
13
Calls
$470M
Puts
$416M
Top Buyers
| 1 | +$767M | |
| 2 | +$268M | |
| 3 | +$133M | |
| 4 |
ClearBridge Investments
New York
|
+$127M |
| 5 |
Holocene Advisors
New York
|
+$111M |
Top Sellers
| 1 | -$339M | |
| 2 | -$145M | |
| 3 | -$128M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$121M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$111M |